ATNM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Actinium Pharmaceuticals Inc (ATNM) is not a strong buy for a beginner long-term investor at this time. The technical indicators are neutral to bearish, options sentiment is weak, and the financial performance shows significant losses. There are no positive catalysts or recent news to support a bullish outlook. Given the user's preference for long-term investment and the lack of strong signals, holding off on this stock is recommended.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 45.159, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.116, with key resistance at 1.188 and support at 1.043. Overall, the technical indicators suggest a neutral to bearish trend.
NULL. No recent news or events to act as a positive catalyst. Gross margin remains at 100%, but revenue growth is stagnant.
Technical indicators are bearish, and the stock has a 40% chance of declining in the short term based on historical patterns.
In Q3 2025, revenue remained flat at $90,000 (0.00% YoY growth). Net income dropped significantly to -$5,131,000 (-55.64% YoY), and EPS fell to -0.16 (-56.76% YoY). While gross margin is at 100%, the company's financials indicate poor profitability and declining performance.
No recent analyst ratings or price target changes are available. Wall Street sentiment is neutral, with no significant hedge fund or insider trading activity.
